ArticleAnalytical chemistry2026
HaloTag-Based FACS-Compatible Assay for Intracellular Haloalkane Detection with a Potential Application to Halogenase Screening.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Halogenases are attractive catalysts to facilitate asymmetric Csp3-halogenation of organic molecules. Traditional halogen insertion reactions employ hazardous reagents and are notoriously unselective, but asymmetric halogenation of drug molecules offers control over pharmacokinetic properties. To date, the toolbox of halogenases to facilitate Csp3-halogenation, and consequently the accessible substrate scope, is limited. Thus, discovering novel enzymatic halogenation reactions has great application potential. One way of achieving this is to screen large libraries of putative halogenases. However, there are currently no suitable (ultra)high-throughput methods available for screening such an immense sequence space to discover halogenases with new substrate profiles. To address this shortcoming, we introduce here a flow cytometry-based assay concept to screen for the intracellular presence of haloalkanes. Our strategy relies on catalytically deficient haloalkane dehalogenases (HLDs), here called HaloTag-like proteins (HTLPs), which can irreversibly trap haloalkanes. For the presented proof-of-concept, we employed the commercialized HaloTag and fused it to the enhanced green fluorescent protein (eGFP), constructing a fluorescent sensor protein that allows semiquantitative detection of haloalkanes at single-cell resolution. We successfully validated our concept by separating mixed populations of Escherichia coli cells that were either exposed or not exposed to six haloalkanes. Moreover, we show that populations can be distinguished based on halohydrin dehalogenase activity. In summary, we provide an assay concept for detecting the intracellular presence of haloalkanes, which has the potential of being applied toward the detection of halogenase activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.